Active Not Recruiting NA INTERVENTIONAL 1-arm NCT05663294

PBI for Breast in Situ Carcinoma of Intermediate Low Risk As Local Adjuvant Treatment (PRISCILLA)

Partial Radiotherapy for Breast in Situ Carcinoma of Intermediate Low Risk As Local Adjuvant Treatment

Sponsor: Istituto Clinico Humanitas

Interventions brachytherapy external beams radiotherapy

Updated 5 times since 2023 Last updated: Jan 30, 2025 Started: Jan 9, 2023 Primary completion: Dec 31, 2029 Completion: Dec 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05663294, this NA trial focuses on Breast Cancer and remains ongoing. Sponsored by Istituto Clinico Humanitas, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Mar 2025 — Present [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Sep 2024 — Mar 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2023 — Jul 2024 [monthly]

Recruiting NA
Jan 2023 — Feb 2023 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istituto Clinico Humanitas
Mediolanum Cardio Research

Data source: Istituto Clinico Humanitas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rozzano, Italy